Profil
Branden S.
Moriarity holds the position of Chief Scientific Officer at B-MoGen Biotechnologies, Inc., founded in 2015.
Dr. Moriarity holds the position of Chief Innovation Officer at Luminary Therapeutics, Inc., founded in 2019.
Dr. Moriarity is the founder of B-MoGen Biotechnologies, Inc. Dr. Moriarity is the founder of Luminary Therapeutics, Inc. Dr. Moriarity is also the founder of Catamaran Bio, Inc...
Aktiva positioner av Branden S. Moriarity
| Företag | Position | Start |
|---|---|---|
B-MoGen Biotechnologies, Inc.
B-MoGen Biotechnologies, Inc. BiotechnologyHealth Technology Provides gene editing solutions for antibody validation, human disease research, gene transfer, and mitochondrial DNA editing | Grundare | 2015-01-01 |
Luminary Therapeutics, Inc.
Luminary Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops non-viral autologous cell therapies | Grundare | 2019-01-01 |
Tidigare kända positioner av Branden S. Moriarity
| Företag | Position | Slut |
|---|---|---|
Catamaran Bio, Inc.
Catamaran Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company developing allogeneic, off the shelf CAR-NK cell therapies for cancer treatment | Grundare | - |
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 3 |
|---|---|
B-MoGen Biotechnologies, Inc.
B-MoGen Biotechnologies, Inc. BiotechnologyHealth Technology Provides gene editing solutions for antibody validation, human disease research, gene transfer, and mitochondrial DNA editing | Health Technology |
Luminary Therapeutics, Inc.
Luminary Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops non-viral autologous cell therapies | Commercial Services |
Catamaran Bio, Inc.
Catamaran Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company developing allogeneic, off the shelf CAR-NK cell therapies for cancer treatment | Health Technology |
















